Skip to main content

13 August 2026

Last updated: Thursday 13 August 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Targeting new medicines at Roche

Sunday 12 January 2014

Interviewee/Contributor

Max Hasmann

Organisation

Roche Group

Organisations

CNS Pharmaceuticals Inc
Innate Pharma SA
MoonLake Immunotherapeutics AG
Cell Medica Ltd
Clavis Pharma ASA
Vertex Pharmaceuticals Inc
MorphoSys AG
Cardiac3 BioSciences SA
Quell Therapeutics Ltd
Howrey LLP

Interviewees and Contributers

John Fielden
Victoria English
Florian Bazant-Hegemark
Donald Light
Hugh Laverty
Pierre Vandepapelière
Roger Pertwee
Graeme Martin
Montserrat Vendrell
Urban Lendahl

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

ViCentra appoints CFO and adds a board member

Wednesday 22 July 2026

New CEO at Simris Biologics

Wednesday 22 July 2026

New CEO at Genopore

Wednesday 22 July 2026

Camena Bioscience appoints CEO

Wednesday 22 July 2026

Lundbeck promotes research head to EVP R&D

Wednesday 22 July 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form